Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Correction to Fluralaner 5.46% (ww) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
Home
Correction to Fluralaner 5.46% (ww) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
digitalplatforms
April 23, 2025
0 Comments
File Type:
pdf
File Size:
479 KB
Categories:
Publications
Post navigation
Previous
Correction Tick communities of cattle in smallholder rural livestock production systems in sub-Saharan Africa
Next
Assessment of the Efficacy of Firocoxib and Robenacoxib in an Induced Synovitis Model of Acute Arthritis in Dogs
